SAM
ONC

SEB Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

SEB Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
41,179
-14,899
-27% -$4.39M 0.04% 310
2026
Q1 		$16.7M Buy
+56,078
New +$18.2M 0.07% 229

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SEB Asset Management's ONC Position: Q2 2026 in Review

SEB Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 27% in Q2 2026, selling an estimated $4.39M and leaving 41,179 shares worth $11.7M. The position accounts for 0.04% of the portfolio, ranked #310.

SEB Asset Management first reported a position in ONC in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.7M in Q1 2026. 273 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • SEB Asset Management held 41,179 shares of BeOne Medicines Ltd worth $11.7M as of Q2 2026.
  • SEB Asset Management sold 14,899 BeOne Medicines Ltd shares in Q2 2026, an estimated $4.39M.
  • BeOne Medicines Ltd made up 0.04% of SEB Asset Management's portfolio in Q2 2026, its #310 holding.
  • SEB Asset Management first reported a position in BeOne Medicines Ltd in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's BeOne Medicines Ltd position peaked at $16.7M in Q1 2026.
  • 273 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.